BIO - BIO-RAD LABORATORIES, INC.
269.85
-9.180 -3.402%
Share volume: 276,869
Last Updated: 03-06-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.08%
PREVIOUS CLOSE
CHG
CHG%
$279.03
-9.18
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-02-2024 | 10-31-2024 | 02-14-2025 | 05-01-2025 | 07-31-2025 | 10-29-2025 | 02-13-2026 | |
| Assets | |||||||||
| Total Assets | 12.610 B | 9.688 B | 10.603 B | 9.364 B | 9.527 B | 10.214 B | 9.696 B | 10.577 B | |
| Current Assets | 3.061 B | 3.056 B | 3.056 B | 3.030 B | 3.037 B | 2.811 B | 2.842 B | 2.906 B | |
| Inventories | 783.369 M | 803.693 M | 804.276 M | 760.000 M | 790.100 M | 798.800 M | 783.200 M | 740.700 M | |
| Other Current Assets | 38.782 M | 32.376 M | 28.158 M | 30.700 M | 36.000 M | 19.000 M | 23.500 M | 27.700 M | |
| Short Term Investments | 1.212 B | 1.209 B | 1.212 B | 1.176 B | 1.139 B | 1.005 B | 1.023 B | 1.011 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 433.280 M | 406.913 M | 410.377 M | 488.100 M | 521.400 M | 369.300 M | 395.800 M | 529.800 M | |
| Total Non-current Assets | 8.018 B | 5.100 B | 6.003 B | 4.839 B | 4.994 B | 5.577 B | 5.058 B | 6.104 B | |
| Property Plant Equipment | 522.364 M | 533.767 M | 545.304 M | 528.100 M | 528.500 M | 549.700 M | 540.200 M | 539.900 M | |
| Other Assets | 9.027 B | 6.098 B | 7.003 B | 5.806 B | 5.962 B | 6.853 B | 6.314 B | 7.130 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 12.610 B | 9.688 B | 10.603 B | 9.364 B | 9.527 B | 10.214 B | 9.696 B | 10.577 B | |
| Total liabilities | 3.559 B | 2.910 B | 3.116 B | 2.795 B | 2.848 B | 3.085 B | 2.960 B | 3.123 B | |
| Total current liabilities | 466.154 M | 486.961 M | 497.943 M | 467.800 M | 506.600 M | 548.900 M | 522.300 M | 517.000 M | |
| Accounts Payable | 102.750 M | 126.693 M | 122.185 M | 122.300 M | 137.900 M | 139.300 M | 128.800 M | 129.000 M | |
| Other liabilities | 352.232 M | 344.512 M | 341.550 M | 308.600 M | 299.400 M | 374.400 M | 363.300 M | 344.800 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.199 B | 1.200 B | 1.200 B | 1.200 B | 1.201 B | 1.201 B | 1.201 B | 1.202 B | |
| Other liabilities | 352.232 M | 344.512 M | 341.550 M | 308.600 M | 299.400 M | 374.400 M | 363.300 M | 344.800 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.051 B | 6.779 B | 7.488 B | 6.569 B | 6.679 B | 7.129 B | 6.737 B | 7.454 B | |
| Common stock | 462.630 M | 474.732 M | 448.332 M | 463.200 M | 475.700 M | 484.600 M | 461.900 M | 476.000 M | |
| Retained earnings | 9.645 B | 7.479 B | 8.132 B | 7.416 B | 7.480 B | 7.798 B | 7.456 B | 8.176 B |